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Summary. Four questionnaire surveys were conducted
over a penod of 20 years to evaluate long-term effects of
haemophilia treatment in the Netherlands. The response
to the prestructured questionnaires in 1972, 1978, 1985
and 1992 vaned between 70% and 84%. Data concerned
treatment modahties, bleeding episodes, hospitahzation,
absenteeism, jomt impairment and employment. Results
over the penod 1972—92 for patients with severe and
moderately severe haemophilia showed that the use of
prophylaxis had sharply increased (from 21% to 45%), äs
was the case for home treatment (from 4% to 62%)
Consequently, the annual mean number of bleeds
dimimshed from 19 to 13. Absence from school was
markedly reduced (from 32 to 5 days), and sick leave in
employed patients had also dimimshed (from 26 to 22
days). Furthermore, the use of mpatient hospital facihties,
äs well äs employment in haemophilia patients, had nearly
equalled that of the general Dutch male population. The
self-reported degree of jomt impairment showed no
overall improvement, but in patients aged under 35 years
there seemed to be a shght reduction in severe impair-
ment. Patients aged under 15 years finally had no severe
impairment at all. Social parncipation can only be further
improved if arthropathy is prevented from an early age.
Therefore adequate prophylactic regimens and close
monitonng of )omt impairment in young adults are
needed.
Keywords haemophilia, prophylaxis, home treatment,
hospitahzation, absenteeism, )omt impairment.
At the end of the 1960s, clotting factor products became
available for Substitution therapy in haemophilia and a
new era in haemophilia care began. Since then the
physical, psychological and social condition of haemo-
philia patients has gradually improved [1—5]. In patients
with a high frequency of bleeds, i.e. with severe or
moderately severe haemophilia, there has been a shift
from on-demand treatment to more prophylactic therapy.
Prophylaxis from an early age was expected to be effective
in reducing the morbidity of haemophilia, especially in
terms of preventing haemarthroses and haemophilic
arthropathy [l, 6, 7]. Home treatment was introduced in
the early 1970s to optimahze the treatment in patients
with a high bleeding tendency. The Situation in which
patients themselves admimster factor concentrates at
home or with the help of others, allows for the early
treatment of bleeding episodes before the appearance of
physical signs [8]. Consequently, arthropathy can be
prevented, and this might subsequently lead to a reduction
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of absenteeism from school or work and a dimimshed
reliance on hospital facihties [8-10].
To evaluate the long-term effects of modern haemo-
phiha treatment on a large scale, we conducted four
national questionnaire surveys among haemophilia
patients. This article reports on the results collected over
a penod of two decades (1972—92). By companng cross-
sectional data on the number of bleeding episodes,
hospitahzation, absenteeism, jomt impairment, and
social participation, we descnbe the extent to which a
change in treatment modahties contnbuted to an
improvement in the medical and social circumstances of
haemophihacs. Compansons with national statistics on
absenteeism, hospitahzation, and social participation will
show whether further improvements can be established.
Methode
Patients and procedures. Four nationwide postal surveys
were conducted m 1972, 1978, 1985 and 1992. The study
population consisted of haemophilia patients who were
hsted with the Netherlands Hemophilia Society, with the
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haemophiha treatment centres, or on updated maihng lists
from our previous survey(s). An extensive search for
addresses enabled us to send questionnaires to 639, 1051,
1162 and 1263 patients, respectively. The response was
calculated for all questionnaires returned, irrespective of
diagnosis (i.e. haemophiha or other bleeding disorders)
and whether the received forms were fully completed.
Only participants diagnosed with haemophiha A or B
were mcluded in the final analyses. The seventy of
haemophiha was classified according to the residual
percentage of factor VIII or IX clotting activity. severe
(<1%), moderate (1-5%), or mild (>5%). The self-
reported type and seventy of haemophiha was venfied
with data obtamed from the treatment centres.
All four prestructured questionnaires covered the
following issues the current treatment modahty and
regimen, the presence of Inhibitors, the annual number of
bleeding episodes, the use of mpatient hospital care,
absence from school or work, degree of jomt impairment,
employment, and disabihty. The questionnaires also
mcluded new issues raised in haemophihc care, e.g.
home treatment (in 1978) and HIV mfections (1985 and
1992).
Data analyses. Analyses were conducted according to the
seventy of haemophiha. Data on the treatment modahty,
the number of bleeding episodes, the use of hospital
facihties, and absence from school or work referred to the
year that preceded the questionnaire surveys. The use of
prophylaxis refers to a group of patients who predomi-
nantly received prophylaxis, from which we excluded
patients who predommantly received treatment on
demand and short-term prophylaxis at vanous times.
The prevalence of haemophiha in 1992 was estimated
from data of 980 respondents and 240 non-respondents of
whom the date of birth and the seventy classification were
known. The age-specific prevalence was calculated äs the
number of hsted haemophiha patients per 100,000 Dutch
males m each age category.
Self-reported measures on jomt impairment were
obtamed for a senes of jomts, with possible scores of 0
(no impairment), l (some impairment without daily
Problems), 2 (some impairment with daily problems),
and a maximum of 3 (severe impairment with complete
loss of function). Because shoulder jomts and the hips are
seldomly affected [l, 11] and patients with the moderate
form of haemophiha rarely develop chromc arthropathy
[12], scores for ankles, knees and elbows m patients with
severe haemophiha were used in assessmg the degree of
jomt impairment. As jomt impairment progresses with age
and older patients are more hkely to have jomt damage
because of a lack of treatment in the past, the results
presented are stratified for age.
The employment Status was defined for respondents
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aged 15—64 years who were either 'active' (i.e. employed,
with a paid job) or 'mactive' (admimstratively registered
äs unemployed or disabled under the existing Dutch social
security laws). To descnbe social participation in
haemophihacs, an 'mactivity ratio' was calculated by
dividing the proportion of 'mactive' patients with severe
or moderately severe haemophiha by the proportion of
'mactive' Dutch males [2]. Thus, the percentage of
mactive haemophihacs will be relative to the percentage
of mactives in the general male population, and ratlos
exceeding a value of l represent a reduced social
participation of haemophiha patients. Descnptive statis-
tics for age, the use of hospital facihties, absence from
work, and employment were compared to national figures
for the general male population that were provided by
Statistics Netherlands.
Results
Response and participants
The response to the questionnaires was 84% (n = 540) in
1972, 70% (n = 736) m 1978, 81% (« = 941) m 1985 and
78% (n = 983) m 1992. Respondents who were excluded
from analyses concerned patients of whom the type of
haemophiha remamed unknown (1972: n = 48; 1978:
n = 131), those who were carners or patients affected
with other clotting factor deficiencies (1972: « = 44; 1978:
n = 16; 1985. « = 2; 1992: « = 29), and respondents who
returned uncompleted questionnaires with httle or no data
(1972. » = 1; 1978: « = 29; 1985: n = 6; 1992: « = 3). A total
of 447, 560, 933 and 980 participants, meetmg the
inclusion cnteria of having haemophiha A or B, remamed
for analyses.
Seventy-five percent (« = 738) of the patients in 1992
participated in an earher survey, mcludmg 232 patients
who responded to all precedmg surveys. The mean age of
participants mcreased from 21 years in 1972 to 32 years in
1992, but remamed lower than the mean age of Dutch
males which had mcreased from 32 to 36 years over the
same penod. The distnbution of 87% («= 853) with
haemophiha A and 13% (n = 127) with haemophiha B m
1992 was similar in all four surveys. Of all participants in
1992, 39% had severe haemophiha (« = 387), 18% had
moderately severe (« = 173) and 43% had mild haemo-
phiha (« = 420).
Prevalence
The age-specific prevalence of haemophiha in 1992 is
shown in Fig. l, with separate distnbutions for the
severely and non-severely affected patients. The overall
prevalence found m 1992 was 16.3 per 100,000 males. The
maximum prevalence of 20.2 per 100,000 males in the age
© Blackwell Science Ltd
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Fig. 1. Prevalence of haemophiha in the Netherlands m 1992 per
100,000 males, with separate distnbutions for severe and non-severe
haemophiha
group of 15—24 years estimates the prevalence at birth,
whereas lower values in the younger and older age
categones are hkely to be the result of delayed diagnoses
and excess mortality m the past, respectively.
Treatment outcomes in severe and moderately severe
haemophiha
Table l presents an overview of results on treatment
modalmes, frequency of bleeds, hospital admissions, and
absence from school or work for patients with severe or
moderately severe haemophiha. Prophylactic treatment
was prescnbed to 21% (« = 52) of these patients in 1972,
which mcreased to 45% (n = 251) in 1992. The apphcation
of home treatment in these patients showed an even larger
increase from 4% (n = 9) m 1972 to 62% (n = 349)
administenng clotting factor products at home in 1992.
The mean number of manifest bleeds per year in patients
with severe or moderately severe haemophiha dechned
from 19 in 1972 to 13 m 1992. The decrease was most
prominent in the severely affected patients, who reported
25 bleeds per year m 1972 and 16 m 1992. The most
frequent sites of haemorrhages m 1992 were joints (77%),
and only three of the 13 bleeds on average were located in
muscles or soft tissues.
The total number of days spent m a hospital by patients
with severe or moderately severe haemophiha reduced
from, on average, 20 days m 1972 to 3 days m 1992, due to
a gradual dechne in the percentage of patients requirmg
admission and a dimmished duration of stay. Haemo-
phiha patients remamed somewhat more dependent on
hospital care m companson with the average hospital
usage of the Dutch male population m 1992 (3 days versus
l day per year). However, their duration of stay per
admission had become equal to that of Dutch males (10
days). In addition, the use of hospital facihties in patients
with severe haemophiha had become the same äs in those
who were moderately severely affected.
Absenteeism due to haemophiha, m school-going
patients with severe or moderately severe haemophiha,
dimmished from 32 days per year in 1972 to 5 days in
1992. As national statistics on school-absence are not
available, a companson with Dutch males is not possible.
Table 1. Overview of seif reported data obtamed from four questionnaire surveys, presented for patients with
severe and moderately severe haemophiha, the figures m parentheses only refer to patients with severe
haemophiha
1972 1978 1985 1992
n 242 (159) 351 (245) 559 (384) 560 (387)
Mean age 21 (22) 23 (23) 27 (27) 30 (30)
Treatment modahty
Prophylaxis (%) 21 (30) 33 (40) 36 (48) 45 (59)
Home treatment (%) 4 (5) 25 (30) 53 (67) 62 (77)
No of bleeds per year 19 (25) 19 (23) 13 (17) 13 (16)
Hospital admission per year
On average (days/patient) 20 (22) 10 (15) 4 (4) 3 (3)
Admitted (%) 47 (51) 37 (40) 23 (25) 22 (22)
Duration of stay (days/patient) 40 (43) 26 (37) 16 (18) 10 (10)
Absenteeism (days/year)
From school* 32 (40) 15 (17) 9 (-10) 5 (6)
From workf 26 (31) 35 (39) 20 (18) 22 (21)
*Due to haemophiha in patients following füll daytime education
fTotal absence in employed patients aged 15-64 years
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Table 2. Patients with severe haemophiha who reported serious impairment in one or more
main jomts, i e ankles, knees and elbows, with, in parentheses, the mean number of joints
severely damaged, stratified by age
Age
0-4 years
5—14 years
15—24 years
25—34 years
35-44 years
45+ years
All
1972 (n = 159)
(% (mean))
8(01 )
9 ( 0 1 )
25 (0 4)
50 (0 8)
53 (0 9)
82 (1 6)
31 (0 5)
1978 (n = 245)
(% (mean))
0 (00)
11 (02)
17 (0 3)
32 (0 5)
32 (0 6)
65 (1 5)
23 (0 4)
1985 (n = 384)
(% (mean))
0 (00)
6 ( 0 1 )
10 (0 1)
32 (0 6)
47 (0 9)
59 (1 4)
26 (0 5)
1992 (n = 387)
(% (mean))
0 (00)
0 (00)
18 (0 2)
32 (0 6)
52 (1 2)
54 (1 4)
31 (0 7)
Sick leave from work m haemophihacs aged 15-64 years
showed a less marked declme, with a reduction from 26
days in 1972 to 22 days per year in 1992. From the self-
reported data in 1992 it was calculated that 15 of the 22
days of absence (68%) were attnbutable to haemophiha.
Absenteeism from work in 1992 was still 9 days higher in
employed patients äs compared to Dutch males who
reported on average 13 days of absence per year.
Jotnt impairment
Table 2 shows percentages of severe haemophiha patients
who reported serious jomt impairment (score 3) in at least
one of their ankles, knees or elbows, and the mean
number of joints affected (ränge 1-6), stratified by age. No
severe jomt impairment was reported in patients aged 0-4
and 5—14 years in 1992. In the age category of 15—24 years
there was no obvious improvement over the years in the
percentage affected with severe jomt impairment. In
respondents aged 25—34 years this percentage mitially
dropped, from 50% to 32%, but showed no further
change. The overall jomt Status in the age category 35-44
years had not changed over 20 years, although the mean
number of severely-impaired joints had somewhat
mcreased. Older patients (45 + ) had gradually reported
less severe impairment. Altogether, the proportion of
severe haemophiha patients having at least one severely
impaired jomt had not changed over 20 years (31% in
1972 and 1992). Meanwhile, overall scores on the average
number of affected joints had mcreased from 0.5 to 0.7.
Finally, 19% of all patients with severe haemophiha
reported no jomt impairment in 1992. This percentage
was directly related to age no jomt impairment at all m
1992 was reported by 86% of the patients aged 0-4, 61%
of those aged 5—14, 15% of the young adults (15-24 years),
and < 2% of those aged 25 years and over.
Employment and soctal parttcipation
The figures for participation in the national labour force
of patients with severe or moderately severe haemophiha
aged 15-64 years are shown in Table 3. Those listed äs
'active' participators had a paid job, and the category
'mactive' included those who were unemployed, disabled,
early retired, or who participated in voluntary work. The
percentage of patients with severe or moderately severe
haemophiha hsted äs 'mactive' had mcreased over the 20
years. However, äs national statistics for the same time
showed an even larger mcrease in the number of mactive
individuals, the excess of mactivity among patients
compared to Dutch males decreased from 130% in 1972
to 30% m 1992.
HIV mfections
To assess HlV-related changes in outcome on hospitahza-
tion, absenteeism and employment, we estimated firstly
the prevalence of HIV mfections based on answers to the
Table 3. Participation in the national labour force of patients with severe and moderately severe haemophiha aged
15-64 years who did not follow füll daytime education, äs compared to Dutch males, corrected for age
No of active patients (%)
(% active Dutch males)
No of mactive patients (%)
(% mactive Dutch males)
1972
(« = 113)
89 (79)
(91)
24 (21)
(9)
1978
(« = 168)
116 (69)
(85)
52 (31)
(15)
1985
(« = 330)
215 (65)
(77)
115 (35)
(23)
1992
(« = 352)
227 (64)
(73)
125 (36)
(27)
Inactivity ratio
(haemophihacs/Dutch males) 23 21 15 l 3
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Table 4. Prevalence of HIV antibodies in 1992 accordmg to seventy and for all
At risk («) *
At risk and tested («)
Seropositive for HIV (n)
Seropositivity if at risk (%)
Severe
(w = 378)
328
278
43
16
Moderate
(n =173)
136
112
10
9
Mild
(n = 420)
243
138
2
1
All
(n = 980)
707
528
55
11
*Patients who probably have been exposed to HIV infection during 1979—85
questionnaire in 1992 (Table 4). The percentage of HIV-
seropositive patients was calculated for those 'at risk', i.e.
those who were born before June 1985 and had received
treatment with blood products m the penod 1979—85.
Altogether, of 707 patients who had been exposed to
untested blood products 528 (75%) were tested for HIV.
11% (n = 55) of these 528 patients were reported to be
seropositive for HIV antibodies. The highest prevalence of
16% (43/278) was found among patients with severe
haemophilia.
No excess of hospital admissions was observed m
seropositive patients. 17% of the seropositive patients had
to be admitted in 1992 and 22% of the seronegative
patients with severe or moderately severe haemophilia.
However, once admitted, the average duration of stay m
hospital was more than twice äs high in seropositive
patients äs m seronegative patients with severe or
moderately severe haemophilia (32 versus 14 days).
Seropositive patients with severe or moderately severe
haemophilia who were undergoing füll daytime educa-
tion, reported on average 10 days of absence from school.
This was twice äs high äs in seronegative patients with
severe or moderately severe haemophilia (5 days). Sick
leave from work in employed seropositive patients was
not higher: 18 days versus 23 days per year in the
seronegative patients with severe or moderately severe
haemophilia. The mactivity ratio for seropositive patients
was calculated at 1.4 (38% versus 27% m Dutch males),
whereas in seronegative patients this ratio was 1.2.
Discussion
As modern haemophilia treatment aims to prevent
arthropathy, by keeping the clotting factor activity above
1% of its normal value [l, 6] it can be expected that
successful prevention is reflected in a decrease of the
frequency of bleeds and a dimimshed degree of jomt
impairment in severe haemophilia. Therefore, if compre-
hensive care methods were effective, the Situation in severe
haemophihacs would equal that of patients with
moderately severe haemophilia. Subsequently, the social
participation, absenteeism and hospitahzation of haemo-
philia patients would gradually become similar to that of
the general male population.
The true prevalence of haemophilia in the Netherlands
m 1992 was estimated at a value between the overall
prevalence of 16.3 and the estimated maximum of 20.2 per
100,000 males (see Fig. 1). With a total of 7.48 milhon
Dutch male mhabitants in 1992, the total number of
haemophilia patients was approximately 1365 (ränge
1219-1511). Consequently, we reached about 93% of the
Dutch haemophilia population m 1992, and approxi-
mately 72% of all patients participated in the question-
naire survey. In 1985 these two percentages were
estimated at 95% and 75% [2]. By reaching a large
majonty of the haemophihc population, the reported data
can be generahzed for each seventy category.
Since 1972 the use of prophylaxis m (moderately)
severely affected patients more than doubled and the
apphcation of hörne treatment ended up 15 times higher.
This shift m treatment modahties contnbuted to a
decrease in the annual number of bleeds, especially m
patients with severe haemophilia. Nonetheless, in the
perspective of preventmg all jomt damage by preventing
bleeds, the number of bleeds in patients with severe or
moderately severe haemophilia was still disconcertingly
high. As home treatment allows for prompt treatment, it
is probable that home therapy contnbuted to the 'quality'
of bleeds by reducing the seventy of accompanymg
Symptoms.
Modern haemophilia treatment succeeded in reducing
the dependence on mpatient hospital care, äs hospitahza-
tion in 1992 almost equalled that of the male population.
Nonetheless, m 1992 the absence from school m patients
with severe or moderately severe haemophilia was on
average still 2-3 days higher than in patients with mild
haemophilm, and sick leave from work remamed higher in
employed patients than m Dutch males. The participation
of haemophilia patients in the national labour force m
1992 nearly equalled that of the Dutch male population,
although the absolute number of unemployed and
disabled haemophihacs had increased over the years.
The consequences of HIV infections were reflected most
obviously in the duration of hospital admission and
absence from school m 1992. Although we must be careful
in interpretmg the analyses with regard to the self-
reported HIV test Status in 1992, we tend to conclude that
seropositivity did not result m any clear changes m the
ι Blackwell Science Ltd Haemophilia (1995), l, 165-171
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outcome measures used for assessing the effects of modern
treatment. However, the 11% seropositivity for haemo-
phiha patients in the Netherlands may have an impact
that goes beyond the outcome reported in this article. The
same might hold true for hepatitis infections, but because
no self-reported test results on hepatitis were available we
cannot report on the consequences of hepatitis in this
article. In a recent study we showed the impact of virus
infections on mortality, with AIDS and liver disease
becommg the main causes of death [13].
Contrary to expectation, the overall percentage of
patients reporting severe jomt impairment had not
changed over 20 years. Despite the fact that factor
preparations were readily available at an early age m
patients born in the 1960s, no obvious improvement m the
joint Status was observed for patients aged under 35 years
in 1992. It can be questioned whether the self-rated degree
of joint impairment used m the four questionnaire surveys
is an accurate measure for assessing the effects of modern
treatment methods. The Orthopedic Advisory Committee
of the World Federation of Hemophiha recommended
usmg the orthopaedic and radiological score System
proposed by Pettersson [14]. However, äs there is no
clear relationship between radiological scores and chmcal
observations [15-17] there might also be a discrepancy
between such chmcal measures and self-reported or
subjective scores. Accordmg to Johnson & Babbit [18],
factors such äs motivation, dnve and personality traits
might influence the perception of disabihty. In our self-
assessment method it is hkely that amongst temporary
physical effects (e.g. recent acute bleeds) the reported
degree of joint impairment was subject to person-related
factors. Otherwise we would have to conclude that
treatment modahties are still faihng to prevent arthro-
pathy. A more adequate prophylactic treatment regimen,
startmg at an earher age or with higher doses, will then be
needed to produce better functional state. From our cross-
sectional data for 1992 it seems unhkely that the treatment
method is madequate in the Netherlands with respect to
the onset of prophylaxis. Already 48% of patients with
severe haemophilia aged 0-4 years receive prophylaxis,
83% of those aged 5-9, and 89% of patients aged 10-14.
After the age of 15 years the use of prophylaxis declmed,
from 72% m patients aged 15-24 years to 69% in those
aged 20-24 years. Since we did not enquire about the
number of bleeds precedmg the onset of prophylaxis, we
cannot be sure whether young patients received prophy-
lactic treatment in time, i.e. when a process of
arthropathy had not yet been mitiated.
The question anses whether further improvements in
the overall condition of haemophilia patients can be
made. Our Undings over a penod of two decades suggest
that the annual number of bleeds, absence from work and
the degree of joint impairment can be dimmished, and
Haemophilia (1995), l, 165-171
that social participation can be improved in (severe)
haemophihacs. With respect to joint Status, a reduction is
desirable in the degree of joint impairment reported by
patients who were born at a time when Substitution therapy
already existed. In conclusion, the outcome measures over
20 years show that modern haemophilia treatment has led
to improvements m the medical and social condition of
patients. However, figures on the frequency of bleeds,
absenteeism, joint impairment, and social participation can
be improved further. Unless more attention is given to the
prevention of (initial) joint damage, especially in adoles-
cents and young adults, social mactivity in terms of
disabihty and unemployment will remain higher in
haemophihacs than m the general male population. We
stress the importance of closely monitonng young adults in
whom initial joint damage may occur or progress.
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